Notable Labs Ltd (NAS:NTBL)
$ 0.8 -0.01 (-1.23%) Market Cap: 7.21 Mil Enterprise Value: 967,000.00 PE Ratio: 0 PB Ratio: 0.48 GF Score: 18/100

Q2 2020 Vascular Biogenics Ltd Earnings Call Transcript

Aug 13, 2020 / 12:30PM GMT
Operator

Greetings and welcome to the VBL Therapeutics Second Quarter 2020 Earnings Conference Call. (Operator Instructions)

As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Michael Wood of LifeSci Advisors.

Please go ahead, sir.

Michael Wood
LifeSci Advisors, LLC - MD of Communications

Thank you, operator. Good morning and thank you all for participating in today's second quarter 2020 results and corporate update call for VBL Therapeutics.

Leading the call today will be Professor Dror Harats, CEO of the company; and Amos Ron, the company's CFO. A press release with the financial results became available at 7:00 a.m. Eastern Time today and can be found on the Investors page of the company's website at vblrx.com.

Before we begin, I'd like to remind everyone that various remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. VBL cautions that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot